CRS
Overvalued by 92.9% based on the discounted cash flow analysis.
Market cap | $11.70 Billion |
---|---|
Enterprise Value | $12.25 Billion |
Dividend Yield | $0.8 (0.340425531914894%) |
Earnings per Share | $3.75 |
Beta | 1.33 |
Outstanding Shares | 50,200,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 32.96 |
---|---|
PEG | 2.33 |
Price to Sales | 4.05 |
Price to Book Ratio | 6.71 |
Enterprise Value to Revenue | 4.19 |
Enterprise Value to EBIT | 24.79 |
Enterprise Value to Net Income | 34 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.39 |
No data
No data